Malignant mesothelioma: development to therapy.
J Cell Biochem
; 115(1): 1-7, 2014 Jan.
Article
en En
| MEDLINE
| ID: mdl-23959774
ABSTRACT
Malignant mesothelioma (MM) is an aggressive cancer of the mesothelium caused by asbestos. Asbestos use has been reduced but not completely stopped. In addition, natural or man-made disasters will continue to dislodge asbestos from old buildings into the atmosphere and as long as respirable asbestos is available, MM will continue to be a threat. Due to the long latency period of MM development, it would still take decades to eradicate this disease if asbestos was completely removed from our lives today. Therefore, there is a need for researchers and clinicians to work together to understand this deadly disease and find a solution for early diagnosis and treatment. This article focuses on developmental mechanisms as well as current therapies available for MM.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Amianto
/
Neoplasias Pulmonares
/
Mesotelioma
Tipo de estudio:
Diagnostic_studies
/
Screening_studies
Límite:
Humans
Idioma:
En
Revista:
J Cell Biochem
Año:
2014
Tipo del documento:
Article